Phase II study of anhydro-ara-5-fluorocytidine in adenocarcinoma of gastrointestinal tract, epidermoid carcinoma of lung, head and neck, breast carcinoma and small cell anaplastic carcinoma of lung. A study report of the E.O.R.T.C. early clinical trial cooperative group
- Eur J Cancer (1965). 1978 Feb;14(2):195-201. doi: 10.1016/0014-2964(78)90178-0.
PMID: 75105
DOI: 10.1016/0014-2964(78)90178-0
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Nucleoside Antimetabolite/AnalogResearch Areas: Cancer
-
target: Nucleoside Antimetabolite/AnalogResearch Areas: Cancer